Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Proteq West Nile 2x1 dose

Boehringer Ingelheim
Expiry date:
Active immunisation against West Nile virus.
More info

Proteq West Nile 2x1 dose + syringe

Suspension for injection containing West Nile recombinant canarypox virus (vCP2017). 

The vaccine strain vCP2017 is a recombinant canarypox virus expressing the preM/E genes of West Nile virus. After inoculation, the virus does not multiply in the horse but expresses the protective proteins. As a consequence, these proteins induce protective immunity against equine West Nile disease.

Active immunisation of horses from 5 months of age against West Nile disease. Proteq West Nile reduces the number of viraemic horses. If clinical signs are present, their duration and severity are reduced. 
Onset of immunity: 4 weeks after the first dose of the primary vaccination course. In order to achieve full protection, the full vaccination course of two doses must be given.  

Duration of immunity: 1 year after a full primary vaccination course of two injections.

Route of administation and dosage
For intramuscular use.
Shake gently before use. 

Administer one dose of 1ml, by intramuscular injection, preferably in the neck region, according to the following schedule:
- Primary vaccination course: first injection from 5 months of age, second injection 4-6 weeks later
- Revaccination: a sufficient degree of protection should be achieved after an annual booster injection with a single dose although this schedule has not been fully validated.

More Information
Registration numberREG NL 107618
BrandBoehringer Ingelheim
Chilled itemYes
Active IngredientWest Nile recombinant canarypox virus
Target speciesHorse
Legal status of supplyUDD
Withdrawal period0 days
Expiry dateSep 4, 2022
Units per outer box0
© 2021 Grovet B.V. All rights reserved.